Indications & Dose:
Tumour-induced hypercalcaemia of malignancy. Paget’s diseases of bone . Osteolytic bone metastases.
Adults:
4 mg reconstituted and diluted for infusion with 50 ml of 0.9% w/v saline or 5% w/v glucose solution, given as a single 15 minute intravenous infusion.
Children: Not recommended.
Adult: 5mg IV infusion over at least 15 minutes once a year.
Contraindications:
Hypersensitivity to bisphosphonates. Pregnancy, lactation
Side Effects:
CNS; Agitation, anxiety, confusion, arthralgia, insomnia, somnolence
Cv ; Chest pain, edema, hypotension, bradycardia
EENT ; Conjunctivitis
Gi ; Abdominal pain, anorexia, constipation, diarrhea, dysphagia, nausea, vomiting.
GU ; Deterioration in renal function, renal failure, UTI
Heme; Abdominal pain, anorexia, constipation, diarrhea, dysphagia, nausea, vomiting.
Cautions:
Precautions:
Interaction:
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Severe renal or hepatic impairment. Cardiac failure. Monitor serum calcium, phosphate and magnesium levels. Monitor renal function. Interactions: Aminoglycosides.
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team